미래의학연구재단 2020 4th International Forum on Medical Innovation of Cell & Bio Therapy

Overview Session Program Speaker Pre-Registration FMI & Partners

2020 4th International

Forum on Medical Innovation of
Cell & Bio Therapy

Open Innovation for Advanced Biomedical Science

Friday. Nov 27. 2020 10 AM (GMT+9)Webinar

사전등록 및 설문조사 완료 시 초록집 무료제공

Pre-Registration Attend

Foundation for Medical Innovation (FMI) is a non-profit corporation approved by the Ministry of Science & ICT (MSIT) and established in 2016 for the purpose of investing the promising technologies and research trends that will lead the future medicine/life science for timely supply and effective spread of the latest treatment technique.

Session Program

─ Friday. Nov 27. 2020 10 AM (GMT+9)

AMResearch-centered Startup Support

ㅡ
ㅡ
Allocate Time Duration of time Presentation / Question Agenda Speaker Affiliation
10:00 – 10:05 5' Opening Remarks Hyo-Soo Kim M.D., Ph.D. FAHA(Director, Strategic Center of CBT (Cell & Bio Therapy) for Heart, Diabetes, & Cancer, Korea)
10:05 – 10:10 5' Welcoming Remarks Sang-Dae Han Chairman (Foundation for Medical Innovation, Korea)
10:10 – 10:35 20'/5' Acceleration of Biotherapeutics R&D through OSONG New Drug Development Center Tae-Gyu Lee Head of New Drug Development Support Center (OSONG Medical Innovation Foundation, Korea)
10:35 – 11:00 20'/5' Bio Health Startup Government Policy Trends and Implications Hyun-Chul Kim Director of R&D Strategy (Korea Health Industry Development Institute, Korea)
11:00 – 11:25 20'/5' Post Corona. Are the Rules of Happiness Changing? Kyung-Il Kim Professor (Ajou University, Korea)
11:25 – 11:50 20'/5' How Best Social-Impact Investing Can Boost Biomedical R/D? Bekay Ahn CFRE, CPAE (International Council for Nonprofit Management, Korea)
11:50 – 13:00 70' Lunch

PMMedical Technology Innovations

ㅡ
ㅡ
Allocate Time Duration of time Presentation / Question Agenda Speaker Affiliation
13:00 – 13:25 25' Somatic Mosaicism, Clonal Hematopoiesis and Vascular Diseases Kenneth Walsh Ph.D. (University of Virginia, USA)
13:25 – 13:50 25' Lifestyle Effects on Inflammation and Cardiovascular Disease Filip K. Swirski Ph.D. (Harvard University, USA)
13:50 – 14:20 30' Direct Transplantation of HLA-haplotype Homo iPS Cell-Derived Purified Ventricular Cardiomyocytes for the Treatment of Patients with HFrEF Keiichi Fukuda M.D., Ph.D. (Keio University School of Medicine, Japan)
14:20 – 14:25 5' Coffee Break
14:25 – 14:45 20' COVID-19 and Cardiovascular Disease Kyung-Woo Park M.D., Ph.D. (Seoul National University Hospital, Korea)
14:45 – 15:10 20'/5' AI for Biomedical Sciences Byoung-Tak Zhang Ph.D. (AI Institute, Seoul National University, Korea)
15:10 – 15:30 20' Novel Biological Function of Lymphatic Vessels Gou-Young Koh M.D., Ph.D. (KAIST, Korea)
15:30 – 15:35 5' Closing Remarks Hyo-Soo Kim M.D., Ph.D. FAHA(Director, Strategic Center of CBT (Cell & Bio Therapy) for Heart, Diabetes, & Cancer)

Chairman

Speaker

Pre-Registration

  • Essential InformationAll information are required.

    Name Gender
    Date of Birth Contact Phone Number
    Organization Job Title
    Field Location
    (Final) Academic Degree E-MAIL
    @

    The registered email account will be used when logging in.
    Password Password Confirm
    Nationality

    SECTOR SELECTION기본정보 등록 후 설문이 진행됩니다. 설문까지 완료하셔야 등록이 완료됩니다.

  • Terms and Conditions

    We inform you that this website handles your personal information as follows.

    1. Purpose of collection and use of personal information
    It is used as a participant propensity analysis material to guide the progress of this webinar and to provide the desired service.

    2. Items of personal information to be collected
    Name, gender, date of birth, contact information, field, affiliation, location of affiliation, and e-mail

    3. Retention and use period of personal information
    The registered information is retained for one year after the end of this webinar, and upon request for deletion, the personal information of the requester is immediately deleted in a way that cannot be reproduced.

    4. Provision of personal information to a third party
    The collected personal information is not used for purposes other than the purpose or provided to third parties.

    5. You can refuse to consent to it. However, if there is no consent, the application for participation may not proceed properly.

    Do you agree with the above terms and conditions?

현금영수증 신청

FMI

Related Organization

Thank You

2020 4th International Forum on Medical Innovation of Cell & Bio Therapy has been registered successfully.

Add to outlook calendar